Current Topics in Medicinal Chemistry

Editorial [Hot Topic: Opportunities and Potential Challenges for the Treatment of Metabolic Syndrome (Guest Editors: Kak-Shan Shia and Yu-Sheng Chao)]
pp. 1420-1420(1)
Authors: Shia, Kak-Shan; Chao, Yu-Sheng

A New Perspective of Cannabinoid 1 Receptor Antagonists: Approaches Toward Peripheral CB1R Blockers without Crossing the Blood-Brain Barrier
pp. 1421-1429(9)
Authors: Wu, Yen-Ku; Yeh, Ching-Fang; Wei Ly, Tai; Hung, Ming-Shiu

The Histamine H3 Receptor as a Therapeutic Drug Target for Metabolic Disorders: Status, Challenges and Opportunities
pp. 1430-1446(17)
Author: Plancher, Jean-Marc

Current Advances and Therapeutic Potential of Agents Targeting Dipeptidyl Peptidases-IV, -II, 8/9 and Fibroblast Activation Protein
pp. 1447-1463(17)
Authors: Chen, Shu-Jen; Jiaang, Weir-Torn

Small Molecule 11β- Hydroxysteroid Dehydrogenase Type 1 Inhibitors
pp. 1464-1475(12)
Authors: Sun, Daqing; Wang, Minghan; Wang, Zhulun

Development of Sodium-Dependent Glucose Co-Transporter 2 Inhibitors as Potential Anti-Diabetic Therapeutics
pp. 1476-1512(37)
Authors: Ho, Low-Tone; S. Kulkarni, Suvarn; Lee, Jinq-Chyi

γ-Secretase Substrates and their Implications for Drug Development in Alzheimer's Disease
pp. 1513-1527(15)
Authors: Lleo, Alberto; A. Saura, Carlos

Homology Models in Docking and High-Throughput Docking
pp. 1528-1534(7)
Author: N. Cavasotto, Claudio

Peptide Nucleic Acids with a Structurally Biased Backbone. Updated Review and Emerging Challenges
pp. 1535-1554(20)
Authors: Corradini, Roberto; Sforza, Stefano; Tedeschi, Tullia; Totsingan, Filbert; Manicardi, Alex; Marchelli, Rosangela

γ-Secretase Inhibitors and Modulators for the Treatment of Alzheimer's Disease: Disappointments and Hopes
pp. 1555-1570(16)
Authors: P. Imbimbo, Bruno; A.M. Giardina, Giuseppe

Recent Advances in Small Molecule Inhibitors of VEGFR and EGFR Signaling Pathways
pp. 1571-1590(20)
Authors: Zhong, Haizhen; Phillip Bowen, J.